Citation Impact
Citing Papers
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
2016
Microbiota in health and diseases
2022 Standout
New frontiers in liver resection for hepatocellular carcinoma
2020
Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?
2015
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Hepatocellular carcinoma
2018 Standout
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
2020
Burden of liver diseases in the world
2018 Standout
Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality
2017
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging
2015
Immunological landscape and immunotherapy of hepatocellular carcinoma
2015
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?
2017
Non-alcoholic fatty liver disease
2021 Standout
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma
2017
Global burden of liver disease: 2023 update
2023 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI
2015
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
2021
Clinical states of cirrhosis and competing risks
2017
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatocellular carcinoma
2022 Standout
The gut–liver axis and the intersection with the microbiome
2018
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Impact of Implementing a “FIB‐4 First” Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
2019
Hepatocellular Carcinoma
2019 Standout
A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: CLDQ ‐NAFLD
2017
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease
2020
Enhanced Liver Fibrosis Test as a Reliable Tool for Assessing Fibrosis in Nonalcoholic Fatty Liver Disease in a Clinical Setting
2017
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
2017
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
2016
Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
2019
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases
2018
Works of Anna Pecorelli being referenced
Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase
2018
Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma
2012
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
2015
Prognosis of untreated hepatocellular carcinoma
2014